Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Fulcrum Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +3 vs. Q2 2022
- Shares held
- 52.2M
- +12.2M (+30.4%) vs. Q2 2022
- Total value
- $422.1M
- +$225.5M (+114.7%) vs. Q2 2022
- New holders
- 24
- 38 more added
- Sold out
- 21
- 23 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FULC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $291.3M |
| Q1 2026 | 169 | $550.1M |
| Q4 2025 | 172 | $762.7M |
| Q3 2025 | 129 | $494.9M |
| Q2 2025 | 122 | $374.5M |
| Q1 2025 | 117 | $147.8M |
| Q4 2024 | 119 | $243.4M |
| Q3 2024 | 130 | $196.4M |
| Q2 2024 | 121 | $402.0M |
| Q1 2024 | 126 | $569.7M |
| Q4 2023 | 101 | $412.3M |
| Q3 2023 | 81 | $250.4M |
| Q2 2023 | 88 | $183.2M |
| Q1 2023 | 116 | $172.2M |
| Q4 2022 | 110 | $368.5M |
| Q3 2022 | 105 | $422.1M |
| Q2 2022 | 102 | $196.6M |
| Q1 2022 | 108 | $929.9M |
| Q4 2021 | 110 | $657.3M |
| Q3 2021 | 101 | $1.03B |
| Q2 2021 | 67 | $280.8M |
| Q1 2021 | 68 | $317.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Fulcrum Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 3,528,000 | $28.5M | 1.20% | +172,376+5.1% | Added |
| TRV GP III, LLC | 3,962,202 | $32.1M | 14.00% | 00.0% | Unchanged |
| RTW Investments, LP | 3,985,910 | $32.2M | 0.74% | +24,716+0.6% | Added |
| Ra Capital Management, L.P. | 7,000,000 | $56.6M | 1.21% | +7,000,000 | New |
| FMR LLC | 7,805,642 | $63.1M | 0.01% | +1,678,411+27.4% | Added |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −214,763−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −81,197−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −68,000−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −58,537−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −37,930−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −31,813−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −30,936−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −30,012−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −27,799−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −25,941−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −21,356−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −15,684−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −13,966−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −14,005−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −11,784−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −10,759−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −6,800−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −4,495−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −3,900−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −72−100.0% | Sold out |